OMCL
OMCL
NASDAQ · Health Care

Omnicell Inc

$39.05
+0.55 (+1.43%)
As of Jun 21, 10:06 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.20B
Net Income
2.08M
Gross Margin
42.9%
Profit Margin
0.2%
Rev Growth
-2.9%
D/E Ratio
0.14
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 42.9% 42.9% 58.8% 58.8%
Operating Margin 0.4% 0.4% 6.3% 6.3%
Profit Margin 0.2% 0.2% 4.9% 5.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.20B 1.24B 1.69B 1.69B
Gross Profit 514.46M 530.04M 993.37M 997.17M
Operating Income 5.28M 4.89M 105.91M 107.52M
Net Income 2.08M 1.93M 82.52M 97.89M
Gross Margin 42.9% 42.9% 58.8% 58.8%
Operating Margin 0.4% 0.4% 6.3% 6.3%
Profit Margin 0.2% 0.2% 4.9% 5.8%
Rev Growth -2.9% -2.9% -3.3% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 106.38M 106.38M 510.00M 606.53M
Total Equity 781.60M 781.60M 603.03M 581.87M
D/E Ratio 0.14 0.14 0.85 1.04
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 85.01M 83.21M 161.95M 137.80M
Free Cash Flow 61.22M 53.55M